Randall Barton
Director Técnico/Científico/I+D en NANOVIRICIDES, INC. .
Perfil
Randall W.
Barton's current job is as the Chief Scientific Officer at NanoViricides, Inc. Dr. Barton's former jobs include being the Director-Invitro Cardiovascular Researchat at Boehringer Ingelheim Pharmaceuticals, Inc., Vice President-Drug Discovery at A&G Pharmaceutical, Inc., Principal at the University of Connecticut, and Chief Scientific Officer at Kard Scientific, Inc. Dr. Barton's education history includes an undergraduate degree from Indiana University and a doctorate degree from the University of Tennessee.
Cargos activos de Randall Barton
| Empresas | Cargo | Inicio |
|---|---|---|
| NANOVIRICIDES, INC. | Director Técnico/Científico/I+D | 03/03/2010 |
Antiguos cargos conocidos de Randall Barton.
| Empresas | Cargo | Fin |
|---|---|---|
Kard Scientific, Inc.
 Kard Scientific, Inc. Miscellaneous Commercial ServicesCommercial Services Kard Scientific, Inc. provides contract research services. It offers in vivo and in vitro pharmacology and preclinical research. The company was founded by Rajah Menon in 2002 and is headquartered in Cambridge, MA. | Director Técnico/Científico/I+D | - |
| University of Connecticut | Corporate Officer/Principal | - |
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Corporate Officer/Principal | - |
A&G Pharmaceutical, Inc.
 A&G Pharmaceutical, Inc. BiotechnologyHealth Technology A&G Pharmaceutical, Inc. develops and creates monoclonal antibodies to cancer-specific targets. It focuses on a near-term opportunity to complete development of and commercialize two GP88-based breast cancer diagnostic test kits to improve early detection, diagnosis and treatment of breast cancer. The firm's product Theranostics develops molecular diagnostic tests in tandem with targeted therapeutics. The company was founded by Jun Hayashi, Ginette Serrero, and Gordon H. Sato in June 2000 and is headquartered in Columbia, MD. | Corporate Officer/Principal | - |
Formación de Randall Barton.
| Indiana University | Undergraduate Degree |
| University of Tennessee | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| NANOVIRICIDES, INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
A&G Pharmaceutical, Inc.
A&G Pharmaceutical, Inc. BiotechnologyHealth Technology A&G Pharmaceutical, Inc. develops and creates monoclonal antibodies to cancer-specific targets. It focuses on a near-term opportunity to complete development of and commercialize two GP88-based breast cancer diagnostic test kits to improve early detection, diagnosis and treatment of breast cancer. The firm's product Theranostics develops molecular diagnostic tests in tandem with targeted therapeutics. The company was founded by Jun Hayashi, Ginette Serrero, and Gordon H. Sato in June 2000 and is headquartered in Columbia, MD. | Health Technology |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Health Technology |
Kard Scientific, Inc.
Kard Scientific, Inc. Miscellaneous Commercial ServicesCommercial Services Kard Scientific, Inc. provides contract research services. It offers in vivo and in vitro pharmacology and preclinical research. The company was founded by Rajah Menon in 2002 and is headquartered in Cambridge, MA. | Commercial Services |
- Bolsa de valores
- Insiders
- Randall Barton
